Quarterly report · Q1

Period2022-04-01 → 2022-06-30
Filed2022-08-10
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
MetricValuePeriodScopeSource row
Revenue¥544m2022-04-01 → 2022-06-30Cons.Net sales
Revenue¥1.3bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥461m2021-04-01 → 2021-06-30Cons.Net sales
Operating income−¥163m2022-04-01 → 2022-06-30Cons.Operating income
Operating income−¥119m2021-04-01 → 2021-06-30Cons.Operating income
Ordinary income−¥186m2022-04-01 → 2022-06-30Cons.Ordinary income
Ordinary income−¥418m2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income−¥104m2021-04-01 → 2021-06-30Cons.Ordinary income
Profit before tax−¥294m2022-04-01 → 2022-06-30Cons.Income before income taxes
Profit before tax−¥100m2021-04-01 → 2021-06-30Cons.Income before income taxes
Net income (owners)−¥288m2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)−¥78m2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)−¥94m2021-04-01 → 2021-06-30Cons.Profit loss attributable to owners of parent
Net income−¥288m2022-04-01 → 2022-06-30Cons.Profit loss
Net income−¥93m2021-04-01 → 2021-06-30Cons.Profit loss
Total assets¥14.5bnat 2022-06-30Cons.Assets
Total assets¥16.0bnat 2022-03-31Cons.Assets
Total assets¥14.7bnat 2021-06-30Cons.Total assets (5-year summary)
Total liabilities¥11.1bnat 2022-06-30Cons.Liabilities
Total liabilities¥12.3bnat 2022-03-31Cons.Liabilities
Net assets / equity¥3.4bnat 2022-06-30Cons.Net assets
Net assets / equity¥3.7bnat 2022-03-31Cons.Net assets
Net assets / equity¥3.5bnat 2021-06-30Cons.Net assets (5-year summary)
Cash and deposits¥867mat 2022-06-30Cons.Cash and deposits
Cash and deposits¥852mat 2022-03-31Cons.Cash and deposits
EPS (basic)¥-32.212022-04-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-8.792021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-10.692021-04-01 → 2021-06-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio22.1%at 2022-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio21.9%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio22.3%at 2021-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 20
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-06-30−¥38m
jpcrp040300-q1r_E05443-000Medical Asset Managemetreportable segmentrevenue2022-04-01 → 2022-06-30¥37m
jpcrp040300-q1r_E05443-000Medical Asset Managemetreportable segmentrevenue external2022-04-01 → 2022-06-30¥37m
jpcrp040300-q1r_E05443-000Medical Asset Managemetreportable segmentsegment profit2022-04-01 → 2022-06-30−¥47m
jpcrp040300-q1r_E05443-000Real Asset Managementreportable segmentrevenue2022-04-01 → 2022-06-30¥507m
jpcrp040300-q1r_E05443-000Real Asset Managementreportable segmentrevenue external2022-04-01 → 2022-06-30¥507m
jpcrp040300-q1r_E05443-000Real Asset Managementreportable segmentsegment profit2022-04-01 → 2022-06-30−¥78m
—segment totalrevenue2022-04-01 → 2022-06-30¥544m
—segment totalrevenue external2022-04-01 → 2022-06-30¥544m
—segment totalsegment profit2022-04-01 → 2022-06-30−¥125m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-04-01 → 2021-06-30−¥39m
jpcrp040300-q1r_E05443-000Medical Asset Managemetreportable segmentrevenue2021-04-01 → 2021-06-30¥59m
jpcrp040300-q1r_E05443-000Medical Asset Managemetreportable segmentrevenue external2021-04-01 → 2021-06-30¥59m
jpcrp040300-q1r_E05443-000Medical Asset Managemetreportable segmentsegment profit2021-04-01 → 2021-06-30−¥50m
jpcrp040300-q1r_E05443-000Real Asset Managementreportable segmentrevenue2021-04-01 → 2021-06-30¥402m
jpcrp040300-q1r_E05443-000Real Asset Managementreportable segmentrevenue external2021-04-01 → 2021-06-30¥402m
jpcrp040300-q1r_E05443-000Real Asset Managementreportable segmentsegment profit2021-04-01 → 2021-06-30−¥30m
—segment totalrevenue2021-04-01 → 2021-06-30¥461m
—segment totalrevenue external2021-04-01 → 2021-06-30¥461m
—segment totalsegment profit2021-04-01 → 2021-06-30−¥80m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 315
ItemContextValueUnit
Net salesPrior1YTDDuration_jpcrp040300-q1r_E05443-000MedicalAssetManagemetReportableSegmentsMember58881000JPY
Net salesPrior1YTDDuration_jpcrp040300-q1r_E05443-000RealAssetManagementReportableSegmentsMember402316000JPY
Net salesPrior1YTDDuration_ReportableSegmentsMember461198000JPY
Net salesPrior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember-JPY
Net salesPrior1YTDDuration461198000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q1r_E05443-000MedicalAssetManagemetReportableSegmentsMember-49686000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q1r_E05443-000RealAssetManagementReportableSegmentsMember-30287000JPY
Operating incomePrior1YTDDuration_ReportableSegmentsMember-79973000JPY
Operating incomePrior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember-39172000JPY
Operating incomePrior1YTDDuration-119146000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q1r_E05443-000MedicalAssetManagemetReportableSegmentsMember36830000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q1r_E05443-000RealAssetManagementReportableSegmentsMember506708000JPY
Revenues from external customersCurrentYTDDuration_ReportableSegmentsMember543539000JPY
Revenues from external customersCurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember-JPY
Revenues from external customersCurrentYTDDuration543539000JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q1r_E05443-000MedicalAssetManagemetReportableSegmentsMember-JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q1r_E05443-000RealAssetManagementReportableSegmentsMember-JPY
Transactions with other segmentsCurrentYTDDuration_ReportableSegmentsMember-JPY
Transactions with other segmentsCurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember-JPY
Transactions with other segmentsCurrentYTDDuration-JPY
Net salesCurrentYTDDuration_jpcrp040300-q1r_E05443-000MedicalAssetManagemetReportableSegmentsMember36830000JPY
Net salesCurrentYTDDuration_jpcrp040300-q1r_E05443-000RealAssetManagementReportableSegmentsMember506708000JPY
Net salesCurrentYTDDuration_ReportableSegmentsMember543539000JPY
Net salesCurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember-JPY
Net salesCurrentYTDDuration543539000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q1r_E05443-000MedicalAssetManagemetReportableSegmentsMember-46547000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q1r_E05443-000RealAssetManagementReportableSegmentsMember-78002000JPY
Operating incomeCurrentYTDDuration_ReportableSegmentsMember-124549000JPY
Operating incomeCurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember-37987000JPY
Operating incomeCurrentYTDDuration-162537000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)四半期報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条の4の7第1項
Place of filing cover pageFilingDateInstant
Original text (Japanese)関東財務局長
Filing date cover pageFilingDateInstant2022-08-10
Quarterly accounting period cover pageFilingDateInstant
Original text (Japanese)第19期第1四半期(自 2022年4月1日 至 2022年6月30日)
Company name cover pageFilingDateInstant
Original text (Japanese)株式会社サイトリ細胞研究所(旧会社名 FRACTALE株式会社)
Company name in english cover pageFilingDateInstantText · Plus
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役社長 堀江 聡寧
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)東京都千代田区大手町一丁目1番1号
Telephone number address of registered headquarter cover pageFilingDateInstant03-5501-4100
Name of contact person address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)経営企画部長  関本 秀貴
Nearest place of contact cover pageFilingDateInstant
Original text (Japanese)東京都千代田区大手町一丁目1番1号
Telephone number nearest place of contact cover pageFilingDateInstant03-5501-4100
Name of contact person nearest place of contact cover pageFilingDateInstant
Original text (Japanese)経営企画部長  関本 秀貴
Place for public inspection cover page (text)FilingDateInstantText · Plus
Footnotes cover page (text)FilingDateInstantText · Plus
Edinet codeFilingDateInstantE05443
Fund codeFilingDateInstant-
Security codeFilingDateInstant37500
Filer name in japaneseFilingDateInstant
Original text (Japanese)株式会社サイトリ細胞研究所

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-03-31pass rounding
balance sheet identityconsolidated 2022-06-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-06-30pass